ChangWon C. Lee
Impact in
- Economics and Econometrics top 10%
- Pharmaceutical Economics and Policy
- Health Systems, Economic Evaluations, Quality of Life
- Economic and Financial Impacts of Cancer
Papers in
-
- Pharmaceutical Economics and Policy 7
- Health Systems, Economic Evaluations, Quality of Life 2
-
- Biosimilars and Bioanalytical Methods 5
- Co-authors
- Aaron S. Kesselheim (13 shared papers)Jerry Avorn (6 shared papers)Benjamin N. Rome (3 shared papers)Kerstin Noëlle Vokinger (2 shared papers)Ariadna Tibau (2 shared papers)Thomas J. Hwang (2 shared papers)Chana A. Sacks (1 shared paper)Thomas Grischott (1 shared paper)
- Journals
- Clinical Pharmacology & Therapeutics (2 papers)JAMA Internal Medicine (2 papers)JCO Oncology Practice (1 paper)The Journal of Law Medicine & Ethics (1 paper)Journal of General Internal Medicine (1 paper)
- Partner nations
- United StatesSwitzerlandSpain
In The Last Decade
ChangWon C. Lee
15 papers receiving 307 citations
Peers
Comparison fields: 5 of 75
- Family Practice 9
- Economics and Econometrics 110
- Immunology 54
- Infectious Diseases 31
- Biological Psychiatry 4
Countries citing papers authored by ChangWon C. Lee
This map shows the geographic impact of ChangWon C. Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by ChangWon C. Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites ChangWon C. Lee more than expected).
Fields of papers citing papers by ChangWon C. Lee
This network shows the impact of papers produced by ChangWon C. Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by ChangWon C. Lee. The network helps show where ChangWon C. Lee may publish in the future.
Co-authors
The 25 scholars most cited alongside ChangWon C. Lee, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 81 | |
| 2 | 2021 | 51 | |
| 3 | 2018 | 39 | |
| 4 | 2020 | 34 | |
| 5 | 2020 | 31 | |
| 6 | 2022 | 26 | |
| 7 | 2021 | 15 | |
| 8 | 2021 | 11 | |
| 9 | 2021 | 7 | |
| 10 | 2023 | 5 | |
| 11 | 2020 | 4 | |
| 12 | 2018 | 3 | |
| 13 | 2021 | 2 | |
| 14 | 2020 | 1 | |
| 15 | 2020 | 1 | |
| 16 | 2025 | 0 |
About ChangWon C. Lee
ChangWon C. Lee is a scholar working on Economics and Econometrics, Immunology, Infectious Diseases, Molecular Biology and Health, having authored 16 papers that have together received 311 indexed citations. Recurring topics across this work include Pharmaceutical Economics and Policy (7 papers), Biosimilars and Bioanalytical Methods (5 papers), Vaccine Coverage and Hesitancy (2 papers), Gut microbiota and health (2 papers), Health Systems, Economic Evaluations, Quality of Life (2 papers), Clostridium difficile and Clostridium perfringens research (2 papers), SARS-CoV-2 and COVID-19 Research (2 papers) and Pharmaceutical studies and practices (2 papers). The work is most often cited by research in Family Practice (9 citations), Economics and Econometrics (110 citations), Immunology (54 citations), Infectious Diseases (31 citations) and Biological Psychiatry (4 citations). ChangWon C. Lee has collaborated with scholars based in United States, Switzerland and Spain. Frequent co-authors include Aaron S. Kesselheim, Jerry Avorn, Benjamin N. Rome, Kerstin Noëlle Vokinger, Ariadna Tibau, Thomas J. Hwang, Chana A. Sacks, Thomas Grischott, Thomas Rosemann and Paola Daniore. Their work appears in journals such as Clinical Pharmacology & Therapeutics, JAMA Internal Medicine, JCO Oncology Practice, The Journal of Law Medicine & Ethics and Journal of General Internal Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.